SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001701541-21-000016
Filing Date
2021-03-25
Accepted
2021-03-25 07:11:05
Documents
16
Period of Report
2021-03-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bdtx-20210325.htm   iXBRL 8-K 35602
2 EX-99.1 bdtx-exhibit991_q42020.htm EX-99.1 76633
8 GRAPHIC logo1.jpg GRAPHIC 14262
  Complete submission text file 0001701541-21-000016.txt   284788

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bdtx-20210325.xsd EX-101.SCH 2471
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bdtx-20210325_cal.xml EX-101.CAL 742
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bdtx-20210325_def.xml EX-101.DEF 1675
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bdtx-20210325_lab.xml EX-101.LAB 24975
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bdtx-20210325_pre.xml EX-101.PRE 13219
9 EXTRACTED XBRL INSTANCE DOCUMENT bdtx-20210325_htm.xml XML 11366
Mailing Address ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Filer) CIK: 0001701541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39200 | Film No.: 21770102
SIC: 2836 Biological Products, (No Diagnostic Substances)